We were very happy with the pH Associates patient centred outcome team’s comprehensive approach to selecting PRO instruments for a real world evidence study. Key domains were identified and mapped against known PRO instruments to develop a robust questionnaire that covered all key domains relevant to IBD patients. This work has recently been published at a highly regarded international conference. Thank you
Our experienced team of Researchers offer a feasibility service to verify the availability and suitability of a range of data sources, including evaluation of data comprehensiveness and accuracy, and processes and timescales for data access.
We have experience with a number of data sources including Clinical Practice Research Datalink (CPRD), registry data, local and national clinical audit datasets, and pharmacy data.
pH Associates has access to primary care data powered by The Health Improvement Network (THIN) as well as the Hospital Episode Statistics dataset. THIN is a primary care dataset of medical records for around 14.7 million patients from approximately 400 general practices with more than 500 publications in peer-reviewed journals.
More than 90% of our business at pH is repeat and we pride ourselves on quickly and efficiently delivering high quality projects for our clients. We are experts in the execution of these projects in the UK, and have streamlined our processes to achieve efficient R&D approvals for observational research. We have a proven track record of engaging with a wide network of NHS and academic partners, and we are proud of these relationships. This, alongside our previous NHS and pharmaceutical industry backgrounds, allows us to develop projects with the NHS that meet their needs whilst also successfully achieving our client’s objectives. We feel that all of these factors place us above our competitors in the successful delivery of a real world data projects. In 2016, two of the 5 studies shortlisted for the inaugural RWE award in the prestigious Prix Galien award were for projects designed, delivered and analysed by pH Associates, including the winning project. This entry was an innovative RWE project which collected data retrospectively from patients’ records on the introduction and use of Astellas’ antibiotic, which was launched in 2012 and also received a commendation at UK Prix Galien 2014. Outlining the rationale behind its win in 2016, Professor Sir Michael Rawlins, Chair of the UK Prix Galien judges commented: “A unique series of local service evaluations were conducted in 2013–2014 to evaluate the impact of Astellas’ antibiotic introduction on the NHS”.
What Our Clients Say
pH Associates have been recognised as a leader in the RWE arena for more than 15 years, with over 350 RWE projects successfully delivered and more than 50 publications to our name.
- National Market Access Manager, Takeda UK Ltd.
I’m really happy with the work that you have done … on your recommendations regarding disease-specific PRO instrument selection in the trials. This will hold us in really good stead once we come to launch, so thank you once again for all your great efforts there!Senior Director-Global Pricing & Market Access, Celgene
The team loves working with you and your PRO contributions are tremendousSenior Vice President – Global Clinical Development – BeiGene
We were delighted to work with pH Associates’ Patient Centred Outcomes team who successfully brought together expert UK endocrinologists and conducted a Delphi panel. This Delphi panel was a first step to understanding the characteristics considered ‘important’ by UK hypoparathyroidism experts for defining patients with chronic hypoparathyroidismAssociate Medical Director, Shire UK
I’m very glad to have worked with Catherine and her team at pH Associates on our recent real world evidence and patient outcomes observational study.. Their expertise, dedication and flexibility ensured the project was delivered on time, within budget, and importantly was credible enough to include in an HTA submission. They have a huge amount of experience conducting RWD studies, something that sets them apart from the competitionPharma, Health Outcomes Manager
The pH team have been amazing. They fully grasped and operationalised the RWE project for us in a swift and efficient manner and also took care to ensure Medical Expert engagement and our field medical team were involved seamlessness throughout setup and during recruitment. The study is progressing so well I was keen to enlarge the scope and recruit more patients. This study fills a real data gap and its set up and execution has been a career highlight for me. Would wholeheartedly recommend pH as a future partner in deliveringDirector, Global Indication Lead
May I also take this opportunity to thank you and your wonderful team for all the hard work, you and your team have contributed to the study. I personally saw the depth of knowledge and huge amount of time spent in initiating the site. I can honestly say, that in all my time in the NHS and all the site initiations I have attended that PH Associates are heads above the competition and I commend you for your professionalism and integrity and on behalf of the medical team, I would like to thank you for all your hard work and commitment to producing excellent research and most of all patient management. I most definitely look forward to working with you all again, in what I hope is not the too distant future.Medical Advisor
pH have exceeded expectations particularly in designing research to the highest ethical standards, to mutually benefit our NHS clients and usHealth Outcome Programme Manager
Many thanks for doing such a good job in such difficult timelines. Your responsiveness, flexibility and pragmatism was great….the time and motion results form a pivotal part of the NICE response documentHead of Health Economics
Working with pH associates on a psoriasis audit project was a delight. Colleagues from pH were helpful, competent and timely. The audit that was commissioned via pH has since been presented at international meetings and is in the process of being publishedAnthony Bewley
The team were friendly, helpful and very organised and efficient in helping us set up and run the High Grade Glioma Study. I would thoroughly recommend them and would be happy to work with them againProf. Cruickshank
I have worked with pH Associates over a number of years on a number of research programmes. Their approach has always been extremely professional and importantly they understand and engage clinicians effectivelyProfessor Derek Bell
I have worked closely with pH Associates as part of a two phase study in the management of pulmonary embolism. Their ability to organise the project, recruit new centres and execute the study has been exemplary. With their assistance and drive we were able to gather collaborative data across centres in the UK, to support a move from in-patient management to ambulatory management in a defined cohort of patientsDr Chris Davies
pH provided a professional and consistent face to a group of important key opinion leaders over a 3 year period. These important customers appreciated the high quality service provided by pH and enthusiastically attended regular Investigator meetings and supported a variety publications.Head of Oncology Business Unit
In the current and future challenging drug development environment – new “pragmatic” ways of profiling the clinical, safety and economic value of an innovative medicines are increasingly important. Careful collection of “real world” data on new medicines is becoming more established and will only become more critical as we move forwards….Vice President